Pandion Therapeutics Appoints Rahul Kakkar, MD, as Chief Executive Officer
Novo Nordisk to award promising start-ups free space at Boston's premier, biotech-capable shared lab facility
HiFiBiO Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders
LabCentral Appoints Biotech Industry Luminary Dr. Susan Windham-Bannister to its Board of Directors
SmartPharm Therapeutics Appoints Fred Driscoll to Board of Directors
